Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - AKCEA THERAPEUTICS, INC. | akca-ex312_9.htm |
| EX-32.1 - EX-32.1 - AKCEA THERAPEUTICS, INC. | akca-ex321_10.htm |
| 10-K - 10-K - AKCEA THERAPEUTICS, INC. | akca-10k_20191231.htm |
| EX-31.1 - EX-31.1 - AKCEA THERAPEUTICS, INC. | akca-ex311_8.htm |
| EX-21.1 - EX-21.1 - AKCEA THERAPEUTICS, INC. | akca-ex211_7.htm |
| EX-23.1 - EX-23.1 - AKCEA THERAPEUTICS, INC. | akca-ex231_11.htm |
| EX-4.5 - EX-4.5 - AKCEA THERAPEUTICS, INC. | akca-ex45_490.htm |
| EX-10.15 - EX-10.15 - AKCEA THERAPEUTICS, INC. | akca-ex1015_357.htm |
Exhibit 10.4
|
|
Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9th Floor Boston, MA 02210
|
Non-Employee Director Compensation Plan
(As of December 2019)
|
|
|
Akcea values the contributions made by its Board of directors. In recognition of these valuable contributions, Akcea will provide each non-employee Director1 with the compensation described in this memo.
Cash Compensation
Each non-employee Director will receive cash compensation based on his/her role on the Board and Board committees:
|
Cash Compensation |
|
|
Board Member (Base retainer) |
$40,000 |
|
Chair of the Board (Additional) |
$30,000 |
|
Committee Chairs (Additional) -Audit -Compensation -Nominating & Gov. -Compliance -Affiliate Transactions -Commercial -Financing
|
$18,000 $12,500 $8,000 $12,500 N/A $12,500 $8,000 |
|
Committee Member (Additional) -Audit -Compensation -Nominating & Gov. -Compliance -Affiliate Transactions -Commercial -Financing |
$9,000 $6,000 $4,500 $6,000 $8,000 $6,000 $4,500 |
Equity Compensation
Each non-employee Director will receive an initial stock option award upon joining the Board, and will receive an annual stock option award for each year of continued service, as follows:
|
Stock Option Award |
No. of Shares |
|
Initial Stock Option Equity Grant |
53,000 |
|
Annual Stock Option Equity Grant |
26,400 |
The exercise price of each option will be the fair market value of Akcea’s common stock on the date of grant.
The options will vest over a four-year period in equal annual installments and be subject to the terms of Akcea’s 2015 Equity Incentive Plan. The vesting of the options will accelerate in the case of a change of control of Akcea, as further described your option agreement and the 2015 Equity Incentive Plan.
Akcea reserves the right to amend this compensation policy at any time.
|
|
1 |
Employees of Ionis who serve on the Akcea Board are not eligible for compensation as Akcea Board members. |